FRANKLIN LAKES, N.J.—BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has announced that Peter Menziuso has been named executive vice president and president, BD Interventional, effective June 1, 2026. Menziuso brings more than 30 years of global healthcare leadership experience and a strong record of driving growth through disciplined execution, BD said in an announcement. He most recently served as company group chairman of Johson & Johnson Vision, where he led a $5 billion global business with responsibility for commercial operations, R&D, supply chain, quality, finance and medical affairs, the announcement said.
